Show simple item record

Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction

dc.contributor.authorAgouni, Abdelali
dc.contributor.authorTual-Chalot, Simon
dc.contributor.authorChalopin, Matthieu
dc.contributor.authorDuluc, Lucie
dc.contributor.authorMody, Nimesh
dc.contributor.authorMartinez, M. Carmen
dc.contributor.authorAndriantsitohaina, Ramaroson
dc.contributor.authorDelibegovic, Mirela
dc.date.accessioned2014-12-04T13:49:01Z
dc.date.available2014-12-04T13:49:01Z
dc.date.issued2014-12-15
dc.identifier.citationAgouni , A , Tual-Chalot , S , Chalopin , M , Duluc , L , Mody , N , Martinez , M C , Andriantsitohaina , R & Delibegovic , M 2014 , ' Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction ' , Biochemical Pharmacology , vol. 92 , no. 4 , pp. 607-617 . https://doi.org/10.1016/j.bcp.2014.10.008en
dc.identifier.issn0006-2952
dc.identifier.otherPURE: 43244449
dc.identifier.otherPURE UUID: 88c33cb3-2081-4a72-981f-468000d80270
dc.identifier.otherScopus: 84912144588
dc.identifier.otherORCID: /0000-0002-2215-7952/work/36967422
dc.identifier.urihttp://hdl.handle.net/2164/4076
dc.descriptionAcknowledgments This work was supported by a Diabetes UK project grant to Dr M. Delibegović (BDARD08/0003597), Tenovus Scotland grant to Dr. M. Delibegovic and Dr. A. Agouni and travel grants from the Physiological Society and Company of Biologists to Dr. A. Agouni. Dr Delibegovic is also funded by an RCUK Fellowship, British Heart Foundation, EFSD/Lilly diabetes programme grant and the Royal Society. Dr Agouni is funded by the Royal Society and the Physiological Society. This work is supported by the INSERM and CHU of Angers. The authors are thankful to the functional imaging center of Angers (CIFAB) for the use of echocardiography.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofBiochemical Pharmacologyen
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Biochemical Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Biochemical Pharmacology, VOL 92, ISSUE 4, (2014) DOI: 10.1016/j.bcp.2014.10.008en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectPTP1Ben
dc.subjectinsulin resistanceen
dc.subjectendothelial dysfunctionen
dc.subjecttyrosine phosphataseen
dc.subjecteNOSen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleHepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunctionen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Biological Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.bcp.2014.10.008
dc.identifier.urlhttp://authors.elsevier.com/a/1Q61R1Rct-f-ren


Files in this item

Thumbnail
Name:
Agouni_et_al_BiochemPharmacolo ...
Size:
1.135Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record